Glomerular fibrin deposition and augmentation of procoagulant activity (PCA) 
Introduction
Fibrin is an important mediator of glomerular injury in proliferative forms of human and experimental glomerulonephritis (GN)' in which macrophage infiltration is prominent (1) (2) (3) (4) . Glomerular fibrin deposition has been shown to be macrophage dependent in a model of anti-glomerular basement membrane antibody-induced GN (anti-GBM GN) in rabbits (5) . However, the mechanism(s) by which macrophages initiate glomerular fibrin deposition is unknown.
In general terms, there are two potential mechanisms for initiation of tissue fibrin deposition, the intrinsic and extrinsic coagulation pathways. In both human (6) and experimental GN (7, 8) , the participation of intrinsic pathway coagulation factors has not been demonstrated. On the other hand, augmented levels of procoagulant activity (PCA) have been demonstrated in isolated glomeruli in experimental (8, 9) and human GN (10) . This glomerular PCA initiates the extrinsic coagulation pathway, and has the functional characteristics of tissue factor, which is also expressed by activated macrophages (10, 11) .
In delayed-type hypersensitivity reactions, lymphocytes may induce macrophages to express augmented PCA and initiate local fibrin deposition (12-15). In GN, however, the cell of origin of the augmented glomerular PCA is unknown. Surface expression of PCA on macrophages and/or PCA induced on intrinsic glomerular cells, such as endothelial cells, by macrophage-derived cytokines, may potentially contribute to augmented glomerular PCA. The expression of PCA by isolated glomerular macrophages and the ability of glomerular macrophage cytokines to stimulate the PCA of intrinsic glomerular cells has not been studied previously.
In these studies, a technique has been developed to isolate macrophages from the glomeruli of rabbits, developing a fibrin-related model of GN (autologous phase anti-GBM GN). The PCA of these isolated glomerular macrophages has been quantitated, characterized, and compared with the PCA content of circulating monocytes and other tissue macrophages (pulmonary alveolar macrophages [PAM] ) in these rabbits, at the same stage of their disease. Further, the capacity of soluble products from nephritic glomeruli and of purified IL 1 to augment the PCA of normal and nephritic rabbit glomeruli has been assessed.
Methods

Experimental model
Anti-GBM GN was induced in New Zealand white rabbits as previously described (8) . Anti-rabbit GBM globulin, raised in a sheep by immunization with rabbit GBM in Freund's complete adjuvant (FCA) (Commonwealth Serum Laboratories, Parkville, Victoria, Australia), was administered to rabbits at a dose shown to bind a mean of 73.6±10.5 ,g of specific kidney fixing antibody per gram wet weight of kidney. Rabbits were killed 6 d later. ments (assessed by phase contrast microscopy). Glomeruli were then cultured in 120 X 75 X 35 mm polystyrene tissue culture flasks (Sterilin Limited, Teddington, Middlesex, UK) at 370C in a 5% C02/air atmosphere, at a concentration of I04 glomeruli per flask. The following culture periods were studied: 1, 4, and 24 h and 3 and 5 d. At the end ofeach culture period, glomeruli from two flasks were removed by decanting the culture medium after vigorous agitation. After a second wash with warm culture medium, < 1% of glomeruli remained in the tissue culture flask. Adherent macrophages were removed by washing with culture medium at 4VC or by incubation for 3 min with trypsinversene solution (Commonwealth Serum Laboratories). Cells harvested by trypsin were washed twice in fresh culture medium. 
Measurement ofPCA
Cell lysates were prepared by sonication using a sonifier cell disruptor (B30; Branson Sonic Power Co., Danbury, CT). Both lysed and unlysed cells were assayed for their PCA content. Unlysed cells were kept overnight at 4VC, and aspirated through a Pasteur pipette to disperse any clumps before assay. PCA was assayed using a standard one-stage clotting assay as previously described (8, 11) . Cells or cell lysate (103 cells in 100 Ml) were prewarmed at 370C for 2 min, together with 100 Ml of 0.025 M calcium chloride in 76 X 9 mm polystyrene tubes. Fresh, citrated, platelet-poor rabbit plasma (100 Al), prewarmed to 370C, was then forcibly added and the clotting time was determined by the manual-tilt method. Cells and cell lysates were assayed in duplicate and diluted 1 in 10 when necessary to extend the clotting time to > 25 s. A value for the PCA was derived by comparison ofthe clotting times with the coagulant activity of standard thromboplastin (Sigma Chemical Co.) prepared from an acetone extract of rabbit brain. 100 Ml of this standard was assigned a value of 1,000 mU of PCA. A 1:100 dilution (10 mU) gave a mean clotting time of 23.9±0.4 s. The activity of the standard (assayed in triplicate) was linear on a log/log plot of clotting time against units ofPCA over the range of0.1 to 100 mU. The PCA of cells and cell lysates was calculated from this standard plot and expressed as mU/ 103 cells.
Characterization ofPCA
Coagulation factor dependence. Factor-deficient human plasmas were used to determine the factor dependency of the glomerular PCA as previously described (11) . The (20) . A cell suspension of thymocytes from 5-7-wk-old C3H/HeJ mice was prepared in RPMI culture medium containing 10% FCS (Flow Laboratories). Thymocytes (5 X 106 per well) were cultured with culture supernatants or known amounts of IL 1 in microtiter plates in the presence of 1 gg/ml PHA (Wellcome Diagnostics, Dartford, England) for 72 h at 37°C in a 5% C02/air atmosphere. Normal rabbit glomeruli. Glomeruli were isolated from normal rabbits by graded sieving and used at a concentration of I04 per ml in 16-mm-diam tissue culture wells, to assess the effect of nephritic glomerular supernatants on the PCA of intrinsic glomerular cells.
Macrophage-depleted nephritic glomeruli. Anti-GBM GN was initiated in rabbits as described earlier. (104) were cultured with supernatants from I04 nephritic glomeruli in a total volume of 1 ml for 4 and 24 h. Controls included glomeruli cultured with culture medium alone, supernatants from normal glomeruli, and with human cell line derived IL 1 (5 U/ml). Glomeruli were aspirated after culture, washed in PBS, sonicated, and stored at -20°C before assay for PCA.
Bovine endothelial cell cultures were used as further controls. Endothelial cells (4.8 X l10) were incubated with supernatants from normal, nephritic, and macrophage-depleted nephritic glomeruli and with IL 1 for 4 h. Supernatants were also heated at 80°C for 15 min to inactivate IL 1 as previously described (22) . Endothelial cells were harvested by incubation for 3 min with trypsin-versene solution, washed in PBS, and kept at 4°C before assay for PCA.
All cultures were performed in duplicate. Glomerular supernatants from six nephritic rabbits, five macrophage-depleted rabbits, and four normal rabbits, as well as appropriate controls, were included in each experiment. Experiments were performed on two separate occasions. Statistical significance was analyzed using the unpaired t test.
Results
Glomerular macrophage yield (Table I ). The yield of purified glomerular macrophages after varying culture times is shown in Table I . The yield increased with longer culture times; however, at 72 h and beyond, intrinsic glomerular cells, identified by their characteristic spreading morphology (2), were also present in the cellular outgrowths. At 72 h, intrinsic cells represented -20% of the outgrowing cells and at day 5, -75%.
Characterization studies. The cells collected for further studies were those that were firmly adherent after washing and Characteristics ofglomerular macrophage PCA (Table III) . PCA of isolated glomerular macrophages exhibited the functional characteristics of tissue factor and was functionally identical to glomerular PCA. The coagulant activity of both glomerular macrophage PCA and whole glomerular PCA was inhibited by the absence of Factors V and VII (glomerular macrophage PCA in Factor V-deficient plasma, 0.5±0.1% of activity in normal plasma, PCA in Factor VII-deficient plasma, 2.3±0.6% of normal) and substantially unaffected by the absence of Factors VIII and XII (PCA in Factor VIII-deficient plasma, 76±1 1%, Factor XII-deficient, plasma 84±15% of normal). Both PCAs were inhibited by preincubation with Con A (PCA 15±3% of control) and phospholipase C (PCA < 1% of control). Con A inhibition was blocked by the addition of the conjugate sugar a-methylmannoside (PCA 95±5% of control). Further, as indicated by comparing lysed and unlysed glomerular macrophages, the majority of the PCA was present on the cell surface membrane.
Effect of soluble factors from nephritic glomeruli on glomerular PCA (Tables IV and V) . The PCA content of normal glomeruli was not significantly augmented by glomerular supernatants or by purified human IL 1. The PCA of macrophage-depleted nephritic glomeruli was also unaffected by culture with these glomerular supernatants or IL 1 (Table IV) . However, culture supernatants from nephritic glomeruli contained significant IL 1 bioactivity in the thymocyte proliferation assay. The IL 1 bioactivity of nephritic glomerular supernatants was 2.7±1.9 U/ml (4-h culture) and 3.3±1.9 U/ml 
Discussion
Fibrin is an important mediator of glomerular injury, associated with loss of renal function and crescent formation in GN. Macrophage-dependent glomerular fibrin deposition and PCA augmentation have previously been demonstrated in passively induced anti-GBM GN in rabbits (5) . The clinical relevance of these observations has been highlighted recently by studies demonstrating markedly augmented levels of tissue factor in glomeruli from patients with fibrin-and macrophage-associated GN (10) . Local (intraglomerular) augmentation of macrophage PCA and/or augmentation of intrinsic glomerular cell PCA by macrophage cytokines provide potential mechanisms for augmentation ofglomerular PCA and initiation of intraglomerular fibrin deposition by macrophages.
Studies were performed to explore these two potential mechanisms. Macrophages were isolated from glomeruli of rabbits developing anti-GBM GN and their PCA expression was measured. Further, the ability of soluble products from isolated nephritic glomeruli to stimulate PCA expression by endothelial cells and normal and macrophage-depleted nephritic glomeruli in vitro was assessed. The results demonstrate that glomerular macrophages express augmented levels of PCA compared with circulating monocytes or other tissue macrophages from these nephritic rabbits. PCA levels were increased between 2-and 50-fold compared with blood monocytes. The presence of large numbers of macrophages in nephritic glomeruli indicates the possibility that these cells may make a substantial contribution to total glomerular PCA. (24) , and T lymphocytes (25) , as well as other stimuli (26, 27) . FCS has been shown to augment macrophage PCA at low concentrations (1%) but not at higher concentrations (> 10%), such as those used in these studies (28) (32) . There is also some preliminary evidence to suggest heterogeneity of glomerular macrophages with regard to their surface membrane activation markers in rabbits developing crescentic GN (33) .
The potential for cytokines released from glomerular macrophages to augment glomerular PCA has been suggested by previous studies showing that purified IL 1 (22) and tumor necrosis factor a (TNFa) (34) (36, 37) . In these studies, supernatants from nephritic glomeruli were shown to contain IL 1 bioactivity. The capacity of these supernatants to stimulate endothelial cell PCA expression was also demonstrated. This stimulating activity was heat labile and therefore not due to endotoxin. IL 1, TNFa, or the combination of these cytokines may contribute to this PCA-stimulating capacity. These results establish the potential for soluble factors from nephritic glomeruli to increase endothelial cell PCA expression. Since the augmented glomerular PCA in this model is dependent on macrophage infiltration (5), glomerular macrophages are the likely source of any PCA stimulating cytokines.
These studies provide evidence for each of the two potential mechanisms (direct macrophage expression of PCA and release of PCA-stimulating cytokines from macrophages) to contribute to the augmentation of glomerular PCA. Evidence for the direct contribution of macrophage PCA is provided by the demonstration ofthe vastly augmented PCA ofglomerular macrophages isolated from nephritic glomeruli. Evidence for stimulation of glomeruliar intrinsic cell PCA by macrophage cytokines is less conclusive. The capacity ofsupernatants from nephritic glomeruli to increase the PCA of isolated endothelial cells has been demonstrated; thus, the potential for this mechanism clearly exists. However, these supernatants did not cause any measurable increase in the PCA of glomeruli in vitro. Inability to reproduce in vivo monokine concentrations and cellular interactions in these in vitro experiments may have accounted for the lack of stimulation ofglomerular PCA. Further studies are necessary to determine the relative contributions of these two mechanisms to the augmented glomerular PCA in this model of anti-GBM GN.
In conclusion, these studies demonstrate that glomerular macrophages collected from rabbits developing a fibrin-dependent model of GN 
